Literature DB >> 26041913

Microglia disrupt mesolimbic reward circuitry in chronic pain.

Anna M W Taylor1, Annie Castonguay2, Alison J Taylor3, Niall P Murphy3, Atefeh Ghogha3, Christopher Cook4, Lihua Xue5, Mary C Olmstead6, Yves De Koninck2, Christopher J Evans3, Catherine M Cahill7.   

Abstract

Chronic pain attenuates midbrain dopamine (DA) transmission, as evidenced by a decrease in opioid-evoked DA release in the ventral striatum, suggesting that the occurrence of chronic pain impairs reward-related behaviors. However, mechanisms by which pain modifies DA transmission remain elusive. Using in vivo microdialysis and microinjection of drugs into the mesolimbic DA system, we demonstrate in mice and rats that microglial activation in the VTA compromises not only opioid-evoked release of DA, but also other DA-stimulating drugs, such as cocaine. Our data show that loss of stimulated extracellular DA is due to impaired chloride homeostasis in midbrain GABAergic interneurons. Treatment with minocycline or interfering with BDNF signaling restored chloride transport within these neurons and recovered DA-dependent reward behavior. Our findings demonstrate that a peripheral nerve injury causes activated microglia within reward circuitry that result in disruption of dopaminergic signaling and reward behavior. These results have broad implications that are not restricted to the problem of pain, but are also relevant to affective disorders associated with disruption of reward circuitry. Because chronic pain causes glial activation in areas of the CNS important for mood and affect, our findings may translate to other disorders, including anxiety and depression, that demonstrate high comorbidity with chronic pain.
Copyright © 2015 Taylor et al.

Entities:  

Keywords:  addiction; affective disorder; chronic pain; dopamine; emotion; opioids

Mesh:

Substances:

Year:  2015        PMID: 26041913      PMCID: PMC4452552          DOI: 10.1523/JNEUROSCI.4036-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  Where is my pain?

Authors:  Valéry Legrain
Journal:  Pain       Date:  2010-12-03       Impact factor: 6.961

2.  Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics.

Authors:  Thomas J Martin; Susy A Kim; Nancy L Buechler; Frank Porreca; James C Eisenach
Journal:  Anesthesiology       Date:  2007-02       Impact factor: 7.892

3.  A multisensory investigation of the functional significance of the "pain matrix".

Authors:  André Mouraux; Ana Diukova; Michael C Lee; Richard G Wise; Gian Domenico Iannetti
Journal:  Neuroimage       Date:  2010-10-12       Impact factor: 6.556

4.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

5.  Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.

Authors:  Neil Schwartz; Paul Temkin; Sandra Jurado; Byung Kook Lim; Boris D Heifets; Jai S Polepalli; Robert C Malenka
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

6.  Correlation between ventral striatal catecholamine content and nociceptive thresholds in neuropathic mice.

Authors:  Anna M W Taylor; Niall P Murphy; Christopher J Evans; Catherine M Cahill
Journal:  J Pain       Date:  2014-06-02       Impact factor: 5.820

7.  BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions.

Authors:  Hector Vargas-Perez; Amine Bahi; Mary Rose Bufalino; Ryan Ting-A-Kee; Geith Maal-Bared; Jenny Lam; Ahmed Fahmy; Laura Clarke; Jennifer K Blanchard; Brett R Larsen; Scott Steffensen; Jean-Luc Dreyer; Derek van der Kooy
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

8.  Minocycline decreases in vitro microglial motility, beta1-integrin, and Kv1.3 channel expression.

Authors:  Nancy Nutile-McMenemy; Arye Elfenbein; Joyce A Deleo
Journal:  J Neurochem       Date:  2007-09-14       Impact factor: 5.372

9.  Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice.

Authors:  Miwako Koizumi; Naoko Midorikawa; Hiroshi Takeshima; Niall P Murphy
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

10.  Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain.

Authors:  Leonardo Guasti; Denise Richardson; Maulik Jhaveri; Khalil Eldeeb; David Barrett; Maurice R Elphick; Stephen P H Alexander; David Kendall; Gregory J Michael; Victoria Chapman
Journal:  Mol Pain       Date:  2009-07-01       Impact factor: 3.395

View more
  59 in total

Review 1.  The risk for problematic opioid use in chronic pain: What can we learn from studies of pain and reward?

Authors:  Patrick H Finan; Bethany Remeniuk; Kelly E Dunn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-01       Impact factor: 5.067

Review 2.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

Review 3.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

4.  RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.

Authors:  Sevasti Gaspari; Valeria Cogliani; Lefteris Manouras; Ethan M Anderson; Vasiliki Mitsi; Kleopatra Avrampou; Fiona B Carr; Venetia Zachariou
Journal:  Neuropsychopharmacology       Date:  2017-01-11       Impact factor: 7.853

5.  Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists.

Authors:  Shaness A Grenald; Madison A Young; Yue Wang; Michael H Ossipov; Mohab M Ibrahim; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Neuropharmacology       Date:  2016-12-20       Impact factor: 5.250

Review 6.  Activity-triggered tetrapartite neuron-glial interactions following peripheral injury.

Authors:  Ke Ren; Ronald Dubner
Journal:  Curr Opin Pharmacol       Date:  2015-09-30       Impact factor: 5.547

Review 7.  Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential.

Authors:  Kazuhide Inoue; Makoto Tsuda
Journal:  Nat Rev Neurosci       Date:  2018-02-08       Impact factor: 34.870

8.  Topography of microglial activation in sensory- and affect-related brain regions in chronic pain.

Authors:  Anna M W Taylor; Sadaf Mehrabani; Steve Liu; Alison J Taylor; Catherine M Cahill
Journal:  J Neurosci Res       Date:  2016-08-30       Impact factor: 4.164

9.  HIV-1 gp120 Upregulates Brain-Derived Neurotrophic Factor (BDNF) Expression in BV2 Cells via the Wnt/β-Catenin Signaling Pathway.

Authors:  Yongdi Wang; Jinxu Liao; Shao-Jun Tang; Jianhong Shu; Wenping Zhang
Journal:  J Mol Neurosci       Date:  2017-05-30       Impact factor: 3.444

Review 10.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.